Keller Guillermo Alberto, Fabian Lucas, Gomez Matías, Gonzalez Claudio Daniel, Diez Roberto Alejandro, Di Girolamo Guillermo
Int J Clin Pharmacol Ther. 2014 Apr;52(4):292-302. doi: 10.5414/CP201957.
Metabolic clearance of isoniazid (INH) may be up to 10 times faster in individuals who are rapid acetylators compared with slow acetylators. In addition, the acetylation phenotype has been suggested to change with age. A better knowledge of the age distribution of the acetylation genotype and phenotype in children requiring INH for tuberculosis treatment or prevention could be important to optimize safety and efficacy of INH use.
The aim of the present study was to evaluate the genotype and phenotype of NAT2 in an Argentinean pediatric population rom Buenos Aires. In addition, we wanted to describe genotype-phenotype correlation, as well as its distribution at different ages.
NAT2 genotyping was performed by RFLP technique, searching for common polymorphisms. Acetylisoniazid and isoniazid concentrations were measured by HPLC and NAT2 phenotype was defined from the ratio of both concentrations (Metabolic Ratio, MR).
Almost half of the patients (46.02%) possessed wild-type haplotype, with 17.05% of individuals having two fully functional alleles, 57.95% one fully functional allele and 25% with no fully functional allele. According to phenotype, most children (96.59%) were classified as fast acetylators, whereas 1.14% of the cases were intermediate and 2.27% slow acetylators. There was a positive association between age and MR (R = 0.52985, p < 0.000001) with a significant MR difference between age categories (p < 0.001).
We found a high proportion of rapid acetylators compared with other populations. Acetylator phenotype showed a positive correlation with age, with a significant change around the 4th year of life.
与慢乙酰化者相比,快速乙酰化者体内异烟肼(INH)的代谢清除速度可能快达10倍。此外,有研究表明乙酰化表型会随年龄变化。更好地了解需要使用INH进行结核病治疗或预防的儿童中乙酰化基因型和表型的年龄分布,对于优化INH使用的安全性和有效性可能很重要。
本研究的目的是评估来自布宜诺斯艾利斯的阿根廷儿科人群中NAT2的基因型和表型。此外,我们想描述基因型与表型的相关性及其在不同年龄的分布情况。
采用RFLP技术进行NAT2基因分型,寻找常见多态性。通过HPLC测量乙酰异烟肼和异烟肼浓度,并根据两者浓度之比(代谢率,MR)定义NAT2表型。
几乎一半的患者(46.02%)拥有野生型单倍型,17.05%的个体有两个功能完全正常的等位基因,57.95%有一个功能完全正常的等位基因,25%没有功能完全正常的等位基因。根据表型,大多数儿童(96.59%)被归类为快速乙酰化者,而1.14%的病例为中间型,2.27%为慢乙酰化者。年龄与MR之间存在正相关(R = 0.52985,p < 0.000001),不同年龄组之间的MR存在显著差异(p < 0.001)。
与其他人群相比,我们发现快速乙酰化者的比例较高。乙酰化表型与年龄呈正相关,在4岁左右有显著变化。